Sexual dimorphism in SARS-COV-2 infection
- PMID: 34084248
- PMCID: PMC8126387
- DOI: 10.4183/aeb.2020.522
Sexual dimorphism in SARS-COV-2 infection
Abstract
Previous studies have demonstrated that female patients with coronavirus disease 2019 (COVID-19) demonstrate more favorable prognosis relative to male patients. In this article, we elaborate the possible role of estrogen in the modulation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection severity. The potential interplay between several factors, including inherently lower estradiol (E2) and slightly higher estrogen receptor β (ERβ) levels in males, with inflammatory mediators are described. Altogether, there seems to be a sexually dimorphic response towards SARS-CoV-2 infection, and a possibility that COVID-19 severity is dependent on both E2 levels and ERα:ERβ expression ratio in lymphoid and lung cells.
Keywords: COVID-19; SARS-CoV-2; Sexual dimorphism; estrogen; estrogen receptor; inflammatory mediator.
©by Acta Endocrinologica Foundation.
References
-
- Ding T, Zhang J, Wang T, Cui P, Chen Z, Jiang J, Zhou S, Dai J, Wang B, Yuan Z, Ma W, Ma L, Rong Y, Chang J, Miao X, Ma X, Wang S. A multi-hospital study in Wuhan, China:protective effects of non-menopause and female hormones on SARS-CoV-2 infection. MedRxiv 2020. doi: 10.1101/2020.03.26.20043943. Available at . - DOI
-
- Mollerup S, Jørgensen K, Berge G, Haugen A. Expression of estrogen receptors alpha and beta in human lung tissue and cell lines. Lung Cancer. 2002;37(2):153–159. - PubMed
-
- Taniuchi S, Fujishima F, Miki Y, Abe K, Nakamura Y, Sato S, Kasajima A, Fue M, Ishida K, Watanabe M, Sakakibara T, Maeda S, Suzuki T, Sasano H. Tissue concentrations of estrogens and aromatase immunolocalization in interstitial pneumonia of human lung. Mol Cell Endocrinol. 2014;392(1-2):136–143. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous